ZURICH, Oct. 17, 2023 /PRNewswire/ -- The Organizing Committee is thrilled to announce the eagerly anticipated EAACI Pediatric Allergy and Asthma Meeting (PAAM) 2023, scheduled to take place from 2nd to 4th November 2023. This event will bring together esteemed experts from around the world to address the pressing challenges and advancements in the field of pediatric allergy and asthma.

The burden of allergic diseases and asthma in children has seen a substantial rise in recent years due to various factors, including differences in lifestyles, changes in food introduction practices, and increased industrialization. Allergy often manifests as a multi-system disorder in children with co-existing conditions such as allergic rhinitis, eczema, and food allergies. These conditions can significantly impact a child's daily life, affecting their school performance, travel, dietary choices, sleep patterns, and social interactions. Families of allergic children and the children themselves face considerable stress and anxiety while adapting to diagnoses, management, and treatment.

The Organizing Committee recognizes the critical need for collaborative efforts among clinicians, emergency services, regulatory authorities, academia, schools, parents, and the affected children to provide effective care and protection for allergic children. PAAM 2023 is a platform where the latest research and scientific breakthroughs are shared to improve the lives of allergic children worldwide.

This year's sessions will delve into the hottest topics in pediatric allergy and immunology, including One-health and its role in environmental and immunomodulation research, food allergy diagnosis, risk assessment, and management, asthma from preschool years to adulthood, the epigenetics of childhood allergy, updates on primary immunodeficiencies, and atopic skin disorders. A special focus will also be placed on delivering better care to children at risk of severe anaphylaxis.

"We look forward to seeing you at PAAM 2023, where we aim to ensure a brighter future for our children by implementing and sharing the highest standards of care within our specialty," says Mohamed Shamji, EAACI Vice President Congresses and member of the Organizing Committee.

In a hybrid format, PAAM 2023 will allow delegates to attend in person in the historic city of Porto, Portugal while offering the flexibility to participate remotely via five tracks. Networking opportunities will be abundant, enabling attendees to engage in discussions with fellow participants and experts.

Visit https://eaaci.org/events_meetings/paam-hybrid-2023/ for registration and program details.

About EAACI

The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization in the field of allergy and clinical immunology. EAACI strives to promote excellence in clinical care, research, education, and training in the field of allergy and clinical immunology. For more information about EAACI, please visit https://eaaci.org/

For more information, please contact our Public Relations and Marketing team at communications@eaaci.org

Contact for Media : Yaozi Moreno +41 44 285 90 49 / María Cubel +41 44 205 55 39

Photo:
Logo:
Logo:

View original content:https://www.prnewswire.co.uk/news-releases/eaaci-pediatric-allergy-and-asthma-meeting-2023-shaping-the-future-of-pediatric-allergy-and-asthma-care-301957881.html

Images

Tags

More Like This

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

EAACI International Severe Asthma Forum (ISAF) Hybrid 2023: Advancing Severe Asthma Care

Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain

Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3

EAACI Congress Kicks Off in Valencia, Spain

Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the EAACI

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024